These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 30920152

  • 1. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T, Zhu X, Wu H, Jiang K, Zhao G, Shaukat A, Deng G, Qiu C.
    J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH.
    PLoS One; 2015 May; 10(7):e0132285. PubMed ID: 26158266
    [Abstract] [Full Text] [Related]

  • 3. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway.
    Wei J, Wu J, Xu W, Nie H, Zhou R, Wang R, Liu Y, Tang G, Wu J.
    Cell Death Dis; 2018 May 22; 9(6):599. PubMed ID: 29789538
    [Abstract] [Full Text] [Related]

  • 4. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, You QD, Guo QL.
    Mol Carcinog; 2014 Feb 22; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [Abstract] [Full Text] [Related]

  • 5. Huaier shows anti-cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF-1α pathway.
    Liu X, Liu L, Chen K, Sun L, Li W, Zhang S.
    J Cell Mol Med; 2021 Feb 22; 25(4):2228-2237. PubMed ID: 33377619
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM, Hernandez F, Puerta N, De Angulo G, Webster KA, Vanni S.
    Exp Mol Med; 2016 Feb 19; 48(2):e210. PubMed ID: 26891914
    [Abstract] [Full Text] [Related]

  • 7. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
    Zhuo B, Li Y, Li Z, Qin H, Sun Q, Zhang F, Shen Y, Shi Y, Wang R.
    Biochem Biophys Res Commun; 2015 Aug 21; 464(2):401-6. PubMed ID: 26116768
    [Abstract] [Full Text] [Related]

  • 8. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose.
    Gao M, Yang Y, Gao Y, Liu T, Guan Q, Zhou T, Shi Y, Hao M, Li Z, Zuo D, Zhang W, Wu Y.
    Chem Biol Interact; 2022 Feb 25; 354():109843. PubMed ID: 35122754
    [Abstract] [Full Text] [Related]

  • 9. Polyphyllin II inhibits breast cancer cell proliferation via the PI3K/Akt signaling pathway.
    Miao W, Wang Z, Gao J, Ohno Y.
    Mol Med Rep; 2024 Dec 25; 30(6):. PubMed ID: 39364737
    [Abstract] [Full Text] [Related]

  • 10. PI3K/AKT pathway promotes keloid fibroblasts proliferation by enhancing glycolysis under hypoxia.
    Wang Q, Yang X, Ma J, Xie X, Sun Y, Chang X, Bi H, Xue H, Qin Z.
    Wound Repair Regen; 2023 Mar 25; 31(2):139-155. PubMed ID: 36571288
    [Abstract] [Full Text] [Related]

  • 11. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.
    Yang X, Gao M, Miao M, Jiang C, Zhang D, Yin Z, Ni Y, Chen J, Zhang J.
    J Pharm Pharmacol; 2021 Mar 04; 73(2):263-271. PubMed ID: 33793802
    [Abstract] [Full Text] [Related]

  • 12. Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.
    Huang SW, Kao JK, Wu CY, Wang ST, Lee HC, Liang SM, Chen YJ, Shieh JJ.
    Oncotarget; 2014 Mar 15; 5(5):1363-81. PubMed ID: 24658058
    [Abstract] [Full Text] [Related]

  • 13. Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.
    Li H, Shi B, Li Y, Yin F.
    J Biochem Mol Toxicol; 2017 Jul 15; 31(7):. PubMed ID: 28266802
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T, Cui L, Wang H, Wang H, Han N.
    J Transl Med; 2018 Jun 14; 16(1):164. PubMed ID: 29898734
    [Abstract] [Full Text] [Related]

  • 15. Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids.
    Lin X, Lin T, Liu M, Chen D, Chen J.
    Biomed Pharmacother; 2024 Jul 14; 176():116871. PubMed ID: 38861856
    [Abstract] [Full Text] [Related]

  • 16. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer.
    Okrah EA, Wang Q, Fu H, Chen Q, Gao J.
    Anticancer Drugs; 2020 Nov 14; 31(10):1046-1056. PubMed ID: 32649369
    [Abstract] [Full Text] [Related]

  • 17. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Wu J, Zhang X, Wang Y, Sun Q, Chen M, Liu S, Zou X.
    Oncol Rep; 2018 Mar 14; 39(3):1181-1190. PubMed ID: 29286170
    [Abstract] [Full Text] [Related]

  • 18. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L, Zhou HY, Tang NN, Zhang WF, He GJ, Hao B, Feng YD, Zhu H.
    World J Gastroenterol; 2016 May 28; 22(20):4868-80. PubMed ID: 27239113
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
    Jung KH, Lee JH, Thien Quach CH, Paik JY, Oh H, Park JW, Lee EJ, Moon SH, Lee KH.
    J Nucl Med; 2013 Dec 28; 54(12):2161-7. PubMed ID: 24221993
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ.
    Mol Cancer Ther; 2007 Feb 28; 6(2):732-41. PubMed ID: 17308069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.